Internal Medicine, Endocrinology, Diabetes, & Metabolism · Thousand Oaks, CA
NPI
1700893815
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
125 W Thousand Oaks Blvd Ste 300
Thousand Oaks, CA, 91360
Phone (805) 418-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$228K
524 services
Medicare patients, 2024
28
Average age 69
Drug cost, 2024
$2.0M
5,162 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph J Pinzone was code 77280 (radiation treatment planning), 206 times for 14 patients. In total Joseph J Pinzone billed 524 services in 6 codes, and Medicare paid $228K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77280 Radiation Treatment Planning | Office | 206 | 14 | $230.21 | $47K |
| 77605 Radiation Oncology | Office | 206 | 14 | $823.07 | $170K |
| 99211 Office E&M - Established | Office | 49 | 11 | $20.89 | $1,024 |
| 77427 Conventional Radiation Treatment | Office | 35 | 12 | $160.52 | $5,618 |
| 99204 Office E&M - New | Office | 26 | 26 | $142.59 | $3,707 |
By year: 2022 $472K for 1,100 services; 2023 $463K for 1,212 services; 2024 $228K for 524 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph J Pinzone prescribed most often to Medicare patients was Levothyroxine Sodium, with 617 prescriptions and refills. In total Joseph J Pinzone wrote 5,162 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 617 | 1,142 | 122 | $4,682 |
| Jardiance Empagliflozin | 491 | 698 | 94 | $396K |
| Metformin Hcl Generic | 489 | 1,035 | 141 | $2,443 |
| Atorvastatin Calcium Generic | 296 | 615 | 81 | $2,317 |
| Pioglitazone Hcl Generic | 273 | 531 | 77 | $3,215 |
| Januvia Sitagliptin Phosphate | 235 | 433 | 54 | $227K |
| Alendronate Sodium Generic | 209 | 374 | 55 | $1,199 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 200 | 383 | 61 | $43K |
| Ozempic Semaglutide | 187 | 230 | 31 | $199K |
| Rosuvastatin Calcium Generic | 182 | 360 | 49 | $2,732 |
| Trulicity Dulaglutide | 174 | 187 | 38 | $177K |
| Rybelsus Semaglutide | 127 | 146 | 39 | $134K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 121 | 301 | 49 | $13K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 91 | 144 | 25 | $70K |
| Farxiga Dapagliflozin Propanediol | 83 | 123 | 19 | $67K |
Brand drugs: 2,326 claims; generic drugs: 2,578 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Joseph J Pinzone were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.